Normal Structure of NFKB 2, C-REL and BCL-3 Gene Loci in Lymphoproliferative and Myeloproliferative Disorders

References

• Baeuerle P A, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141–179
   PubMed Web of Science ®Google Scholar
• Baldwin A S. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649–681
   PubMed Web of Science ®Google Scholar
• Girondakis S, Grumont R, Rourke I, Grossmann M. The regulation of Rel/NF-κB transcription factors during lymphocyte activation. Curr Opin Immunol 1998; 10: 353–359
   PubMed Web of Science ®Google Scholar
• Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994; 10: 405–55
   PubMedGoogle Scholar
• Van Antwerp D J, Martin S J, Verma I M, Green D R. Inhibition of TNF-induced apoptosis by NF-κB. Trends Cell Biol 1998; 8: 107–111
   PubMed Web of Science ®Google Scholar
• Sha W, Liou H C, Tuomanen E I, Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 1995; 80: 321–330
   PubMed Web of Science ®Google Scholar
• Caamano J H, Rizzo C A, Durham S K, Barton D S, Raventós-Suárez C, Snapper C, Bravo R. Nuclear factor (NF)-κB2 (pl00/p52) is required for normal splenic microarchitecture and B cell mediated immune responses. J Exp Med 1998; 187: 185–196
   PubMed Web of Science ®Google Scholar
• Franzoso G, Carlson L, Poljak L, Shores E W, Epstein S, Leonardi A, Grinberg A, Tran T, Scharton-Kersten T, Anver M, Love P, Brown K, Siebenlist U. Mice deficient in Nuclear Factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions and splenic microarchitecture. J Exp Med 1998; 187: 147–159
   PubMed Web of Science ®Google Scholar
• Kontgen F, Grumont R J, Strasser A, Metcalf D, Li R, Tarlinton D, Gerondakis S. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity and interleukin-2 expression. Genes Dev 1995; 9: 1965–1977
   PubMed Web of Science ®Google Scholar
• Weih F, Carrasco D, Durham S K, Barton D, Rizzo C A, Ryseck R P, Lira S A, Bravo R. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/rel family. Cell 1995; 80: 331–340
   PubMed Web of Science ®Google Scholar
• Schwarz E M, Krimpenfort P, Berns A, Verma I M. Immunological defects in mice with a targeted disruption in bcl-3. Genes Dev 1997; 11: 187–197
   PubMed Web of Science ®Google Scholar
• Weih F, Durham S K, Barton D S, Sha W, Baltimore D, Bravo R. p50-NF-κB complexes partially compensate for the absence of RelB: severly increased pathology in p50-/-relB-/- double-knockout mice. J Exp Med 1997; 185: 1359–1370
   PubMed Web of Science ®Google Scholar
• Beg A A, Sha W C, Bronson R T, Baltimore D. Constitutive NF-κB activation, enhanced granulopoiesis and neonatal lethality in IκBα-deficient mice. Genes Dev 1995; 9: 2736–2746
   PubMed Web of Science ®Google Scholar
• Gilmore T D, Koedood M, Piffat K A, White D W. Rel/NF-κB/IκB proteins and cancer. Oncogene 1996; 13: 1367–1378
   PubMed Web of Science ®Google Scholar
• Wu M, Lee H, Bellas R E, Schauer S L, Arsura M, Katz D, FitzGerald M J, Rothstein T L, Sherr D H, Sonenshein G E. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J 1996; 15: 4682–4690
   PubMed Web of Science ®Google Scholar
• Wang C Y, Cusack J C, Liu R, Baldwin A S. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med 1999; 5: 412–417
   PubMed Web of Science ®Google Scholar
• Fracchiola N S, Lombardi L, Salina M, Migliazza A, Baldini L, Berti E, Cro L, Polli E, Maiolo A T, Neri A. Structural alterations of the NF-κB transcription factor lyt-10 in lymphoid malignancies. Oncogene 1993; 8: 2839–2845
   PubMed Web of Science ®Google Scholar
• Neri A, Chang C C, Lombardi L, Salina M, Corradini P, Maiolo A T, Chaganti R SK, Dalla-Favera R. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell 1991; 67: 1075–1087
   PubMed Web of Science ®Google Scholar
• Lu D, Thompson J D, Gorski G K, Rice N, Mayer M G, Yunis J J. Alterations at the rel locus in human lymphoma. Oncogene 1991; 6: 1235–1241
   PubMed Web of Science ®Google Scholar
• Houldsworth J, Mathew J, Rao P, Dyomina K, Louie D C, Parsa N, Offit K, Chaganti R SK. Rel proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood 1996; 87: 25–29
   PubMed Web of Science ®Google Scholar
• Ueshima Y, Bird M L, Vardiman J W, Rowley J D. A t(14;19) translocation in B-cell chronic lymphocytic leukemia: a new recurring chromosomal aberration. Int J Cancer 1985; 36: 287–290
   PubMed Web of Science ®Google Scholar
• Chang C C, Zhang J, Lombardi L, Neri A, Dalla-Favera R. Mechanism of expression and role in transcriptional control of the proto-oncogene NFκB2/lyt-10. Oncogene 1994; 9: 923–933
   PubMed Web of Science ®Google Scholar
• Migliazza A, Lombardi L, Rocchi M, Trecca D, Chang C C, Antonacci R, Fracchiola N S, Ciana P, Maiolo A T, Neri A. Heterogeneous chromosomal aberrations generate 3′ truncations of the NFKB2/lyt-10 gene in lymphoid malignancies. Blood 1994; 11: 3850–3860
   Google Scholar
• Thakur S, Lin H C, Tseng W T, Kumar S, Bravo R, Foss F, Gelinas C, Rabson A B. Rearrangement and altered expression of the NFκB-2 gene in human cutaneous T-lymphoma cells. Oncogene 1994; 9: 2335–2344
   PubMed Web of Science ®Google Scholar
• McKeithan T W, Rowley J D, Shows T B, Diaz M O. Cloning of the chromosome translocation breakpoint junction of the t(14;19) in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1987; 84: 9257–9260
   PubMed Web of Science ®Google Scholar
• Ohno H, Takimoto G, McKeithan T W. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 1990; 60: 991–997
   PubMed Web of Science ®Google Scholar
• Michaux L, Mecucci C, Stul M, Wlodarska I, Hernandez J M, Meeus P, Michaux J I, Scheiff J M, Noel H, Louwagnie A, Criel A, Boogaerts M, Van Orshoven A, Cassiman J J, Van Den Berghe H. Bcl3 rearrangement and t(14;19)(q32;ql3) in lymphoproliferative disorders. Gene Chromosom Cancer 1996; 15: 38–47
   PubMed Web of Science ®Google Scholar
• Ohno H, Doi S, Yabumoto K, Fukuhara S, McKeithan T W. Molecular characterization of the t(14;19)(q32;ql3) translocation in chronic lymphocytic leukemia. Leukemia 1993; 7: 2057–2063
   PubMed Web of Science ®Google Scholar
• Munzert G. Manuscript in preparation
   Google Scholar
• Sambrook J, Fritsch E F, Maniatis T. Molecular cloning - a laboratory manual. 2. Edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 1989
   Google Scholar
• Liptay S, Seriu T, Bartram C, Schmid R M. Germline configuration of nfkb 2, c-rel and bcl3 in childhood acute lymphoblastic leukemia (ALL). Leukemia 1997; 11: 1364–1366
   PubMed Web of Science ®Google Scholar
• Zhang J, Chang C C, Lombardi L, Dalla-Favera R. Rearranged NFκB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions. Oncogene 1994; 9: 1931–1937
   PubMed Web of Science ®Google Scholar
• Schmid R M, Perkins N D, Duckett C S, Andrews P C, Nabel G J. Cloning of an NF-κB subunit which regulates HIV transcription in synergy with p65. Nature 1991; 352: 733–736
   PubMed Web of Science ®Google Scholar
• Kerr L D, Duckett C S, Wamsley P, Zhang Q, Chiao P, Nabel G, McKeithan T W, Baeuerle P A, Verma I M. The proto-oncogene bcl-3 encodes an I kappa B protein. Genes Dev 1992; 6: 2352–63
   PubMed Web of Science ®Google Scholar
• Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, Siebenlist U. The oncoprotein Bcl-3 directly trans-activates through kappa B motifs via association with DNA-binding p50B homodimers. Cell 1993; 72: 729–739
   PubMed Web of Science ®Google Scholar
• McKeithan T W, Ohno H, Dickstein J, Hume E. Genomic structure of the candidate proto-oncogene bcl3. Genomics 1994; 24: 120–126
   PubMed Web of Science ®Google Scholar
• Lishner M, Lalkin A, Klein A, Yarkoni S, Manor Y, Fejgin M, Leytin V, Ravid M, Amiel A. The Bel-1, Bcl-2 and Bcl-3 oncogenes are involved in chronic lymphocytic leukemia. Detection by fluorescence in situ hybridization. Cancer Genet Cytogenet 1995; 85: 118–123
   PubMed Web of Science ®Google Scholar
• Asou H, Takechi M, Tanaka K, Tashiro S, Dohy H, Ohno R, Kamada N. Japanese B cell chronic lymphocytic leukemia: a cytogenetic and molecular biological study. Br J Haematol 1993; 85: 492–497
   PubMed Web of Science ®Google Scholar
• Raghobier S, Van Krieken J H, Kluin-Nelemans J C, Gillis A, Van-Ommen G J, Ginsberg A M, Raffeld M, Kluin P M. Oncogene rearrangements in chronic B-cell leukemia. Blood 1991; 77: 1560–1564
   PubMed Web of Science ®Google Scholar
• McKeithan T W, Takimoto G S, Ohno H, Bjorling V S, Morgan R, Hecht B K, Dube I, Sandberg A A, Rowley J D. Bcl3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study. Genes Chromosomes Cancer 1997; 20: 64–72
   PubMed Web of Science ®Google Scholar
• Brownell E, Mittereder N, Rice N R. A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon. Oncogene 1989; 4: 935–942
   PubMed Web of Science ®Google Scholar
• Ciana P, Neri A, Cappelini C, Cavallo F, Pomati M, Chang C C, Maiolo A T, Lombardi L. Constitutive expression of lymphoma-associated NFKB-2/lyt-10 proteins is tumorigenic in murine fibroblasts. Oncogene 1997; 14: 1805–1810
   PubMed Web of Science ®Google Scholar
• Chang C C, Zhang J, Lombardi L, Neri A, Dalla-Favera R. Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators. Mol Cell Biol 1995; 15: 5180–5187
   PubMed Web of Science ®Google Scholar
• Liptay S, Schmid R M, Perkins N D, Meltzer P, Altherr M R, McPherson J D, Wasmuth J J, Nabel G J. Related subunits of NF-κB map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2. Genomics 1992; 13: 287–292
   PubMed Web of Science ®Google Scholar
• Liptay S, Schmid R M, Nabel E G, Nabel G J. Transcriptional regulation of NF-κB2: evidence for κB-mediated positive and negative autoregulation. Mol Cell Biol 1994; 14: 7695–7703
   PubMed Web of Science ®Google Scholar
• Brownell E, O'Brien S, Nash W, Rice N. Genetic characterization of human c-rel sequences. Mol Cell Biol 1985; 5: 2826–2831
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Stein H, Banks P M, Chan J KC, Cleary M L, Delsol G, De Wolf-Peters C, Falini B, Gatter K C, Grogan T M, Isaacson P G, Knowles D M, Mason D Y, Miiller-Hermelink H K, Pileri S A, Piris M A, Ralfkiaer E, Warnke R A. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar